The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Hemato Oncology Testing is a technology to predict the probability of disease by collecting genes (DNA) in human blood and analyzing and measuring the complete sequence of genes. Genetic testing can identify individuals' genes for disease, thereby preventing or treating tumours earlier.
Hematologic tumor detection is a technique to detect tumor genes on the basis of gene detection. Blood tumor detection services cover a wide range of solid tumors such as lung cancer, breast cancer, stomach cancer, esophageal cancer, colorectal cancer and liver cancer. Common tumors are detected. According to different tumor stages, blood tumor detection can be divided into four categories: tumor susceptibility gene screening, tumor early diagnosis, tumor individualized drug diagnosis, and tumor recovery monitoring. Tumor susceptibility gene screening can help people at high risk of genetic mutations to actively prevent tumors. Early diagnosis of cancer can help patients to find the disease as early as possible, thus greatly improving the survival rate of cancer patients. Individualized drug diagnosis for cancer patients to provide a more accurate cancer treatment program. Tumor recovery was monitored to assess the risk of recurrence.
In this paper, the current status and future development trend of hematoncology testing in China market are studied, focusing on the analysis of the companies that play an important role in the Chinese market, and focusing on the revenue, market share, market positioning, development plans, products and services of these companies in the Chinese market.
The global Hemato Oncology Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In Chinese Market, Hemato Oncology Testing key players include Roche, Berry Genomics, Burning Rock Dx, BGI, Genetron, etc. Global top 5 manufacturers hold a share over 28%.
In terms of product, ctDNA Testing is the largest segment, with a share over 71%. And in terms of application, the largest application is Hospital, followed by Third Party Agency, Others.
This report aims to provide a comprehensive presentation of the global market for Hemato Oncology Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemato Oncology Testing.
Report Scope
The Hemato Oncology Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemato Oncology Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemato Oncology Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company (Partial List)
- Roche
- Berry Genomics
- Burning Rock Dx
- BGI
- Genetron
- Haplox
- Amoy Dx
- Genosaber
- YZY Biopharma
- Wondfo
Segment by Type
- ctDNA Testing
- CTC Testing
- Other Testing
Segment by Application
- Hospital
- Third Party Agency
- Others
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hemato Oncology Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemato Oncology Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 ctDNA Testing
1.2.3 CTC Testing
1.2.4 Other Testing
1.3 Market by Application
1.3.1 Global Hemato Oncology Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Third Party Agency
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hemato Oncology Testing Market Perspective (2019-2030)
2.2 Hemato Oncology Testing Growth Trends by Region
2.2.1 Global Hemato Oncology Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hemato Oncology Testing Historic Market Size by Region (2019-2024)
2.2.3 Hemato Oncology Testing Forecasted Market Size by Region (2025-2030)
2.3 Hemato Oncology Testing Market Dynamics
2.3.1 Hemato Oncology Testing Industry Trends
2.3.2 Hemato Oncology Testing Market Drivers
2.3.3 Hemato Oncology Testing Market Challenges
2.3.4 Hemato Oncology Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hemato Oncology Testing Players by Revenue
3.1.1 Global Top Hemato Oncology Testing Players by Revenue (2019-2024)
3.1.2 Global Hemato Oncology Testing Revenue Market Share by Players (2019-2024)
3.2 Global Hemato Oncology Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hemato Oncology Testing Revenue
3.4 Global Hemato Oncology Testing Market Concentration Ratio
3.4.1 Global Hemato Oncology Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemato Oncology Testing Revenue in 2023
3.5 Hemato Oncology Testing Key Players Head office and Area Served
3.6 Key Players Hemato Oncology Testing Product Solution and Service
3.7 Date of Enter into Hemato Oncology Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemato Oncology Testing Breakdown Data by Type
4.1 Global Hemato Oncology Testing Historic Market Size by Type (2019-2024)
4.2 Global Hemato Oncology Testing Forecasted Market Size by Type (2025-2030)
5 Hemato Oncology Testing Breakdown Data by Application
5.1 Global Hemato Oncology Testing Historic Market Size by Application (2019-2024)
5.2 Global Hemato Oncology Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hemato Oncology Testing Market Size (2019-2030)
6.2 North America Hemato Oncology Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hemato Oncology Testing Market Size by Country (2019-2024)
6.4 North America Hemato Oncology Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hemato Oncology Testing Market Size (2019-2030)
7.2 Europe Hemato Oncology Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hemato Oncology Testing Market Size by Country (2019-2024)
7.4 Europe Hemato Oncology Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hemato Oncology Testing Market Size (2019-2030)
8.2 Asia-Pacific Hemato Oncology Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hemato Oncology Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Hemato Oncology Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hemato Oncology Testing Market Size (2019-2030)
9.2 Latin America Hemato Oncology Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hemato Oncology Testing Market Size by Country (2019-2024)
9.4 Latin America Hemato Oncology Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hemato Oncology Testing Market Size (2019-2030)
10.2 Middle East & Africa Hemato Oncology Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hemato Oncology Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Hemato Oncology Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Hemato Oncology Testing Introduction
11.1.4 Roche Revenue in Hemato Oncology Testing Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Berry Genomics
11.2.1 Berry Genomics Company Detail
11.2.2 Berry Genomics Business Overview
11.2.3 Berry Genomics Hemato Oncology Testing Introduction
11.2.4 Berry Genomics Revenue in Hemato Oncology Testing Business (2019-2024)
11.2.5 Berry Genomics Recent Development
11.3 Burning Rock Dx
11.3.1 Burning Rock Dx Company Detail
11.3.2 Burning Rock Dx Business Overview
11.3.3 Burning Rock Dx Hemato Oncology Testing Introduction
11.3.4 Burning Rock Dx Revenue in Hemato Oncology Testing Business (2019-2024)
11.3.5 Burning Rock Dx Recent Development
11.4 BGI
11.4.1 BGI Company Detail
11.4.2 BGI Business Overview
11.4.3 BGI Hemato Oncology Testing Introduction
11.4.4 BGI Revenue in Hemato Oncology Testing Business (2019-2024)
11.4.5 BGI Recent Development
11.5 Genetron
11.5.1 Genetron Company Detail
11.5.2 Genetron Business Overview
11.5.3 Genetron Hemato Oncology Testing Introduction
11.5.4 Genetron Revenue in Hemato Oncology Testing Business (2019-2024)
11.5.5 Genetron Recent Development
11.6 Haplox
11.6.1 Haplox Company Detail
11.6.2 Haplox Business Overview
11.6.3 Haplox Hemato Oncology Testing Introduction
11.6.4 Haplox Revenue in Hemato Oncology Testing Business (2019-2024)
11.6.5 Haplox Recent Development
11.7 Amoy Dx
11.7.1 Amoy Dx Company Detail
11.7.2 Amoy Dx Business Overview
11.7.3 Amoy Dx Hemato Oncology Testing Introduction
11.7.4 Amoy Dx Revenue in Hemato Oncology Testing Business (2019-2024)
11.7.5 Amoy Dx Recent Development
11.8 Genosaber
11.8.1 Genosaber Company Detail
11.8.2 Genosaber Business Overview
11.8.3 Genosaber Hemato Oncology Testing Introduction
11.8.4 Genosaber Revenue in Hemato Oncology Testing Business (2019-2024)
11.8.5 Genosaber Recent Development
11.9 YZY Biopharma
11.9.1 YZY Biopharma Company Detail
11.9.2 YZY Biopharma Business Overview
11.9.3 YZY Biopharma Hemato Oncology Testing Introduction
11.9.4 YZY Biopharma Revenue in Hemato Oncology Testing Business (2019-2024)
11.9.5 YZY Biopharma Recent Development
11.10 Wondfo
11.10.1 Wondfo Company Detail
11.10.2 Wondfo Business Overview
11.10.3 Wondfo Hemato Oncology Testing Introduction
11.10.4 Wondfo Revenue in Hemato Oncology Testing Business (2019-2024)
11.10.5 Wondfo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
